July DEA Conference on Preventing Drug Diversion Open to Pharmacy Personnel in Wisconsin

Topics: Diversion and Dea

Drug Enforcement Administration (DEA) is offering two regional one-day Pharmacy Diversion Awareness Conferences in Milwaukee, WI, with one on Saturday, July 25, 2015, and another on Sunday, July 26, 2015.

Read More →

More Than 26,000 Overdoses Reversed by Laypersons Administering Naloxone, CDC Reports

Topics: Prescription drug abuse and Cdc

From 1996 through June 2014, organizations surveyed by the Centers for Disease Control and Prevention (CDC) have provided more than 150,000 overdose reversal kits containing naloxone to laypersons who have reported 26,463 overdose reversals in that time. 

Read More →

Daytrana Patch May Cause Permanent Skin Color Changes, FDA Warns

Topics: Fda

Food and Drug Administration (FDA) is warning health care providers and consumers that Daytrana®, a methylphenidate transdermal system prescribed for treating attention deficit hyperactivity disorder may cause permanent loss of skin color in the affected area. 

Read More →

Pennsylvania Governor Signs Law Allowing Pharmacists to Issue Flu Vaccinations to Some Children

Topics: Pharmacists and Vaccinations

Pennsylvania Governor Tom Wolf has signed into law a bill that will allow pharmacists to provide flu vaccinations to people age nine or older.

Read More →

Physician Charged With Illegally Distributing Pain Medications Resulting in Five Fatalities, DEA Reports

Topics: Controlled substances and Diversion

Jaime Guerrero, a former medical physician with offices in Louisville, KY, and Jeffersonville, IN, has been indicted for knowingly distributing and dispensing Schedule II and III controlled substances to patients without a legitimate medical purpose.

Read More →

FDA Takes Action Against More Than 1,050 Websites Selling Counterfeit Prescription Drugs and Medical Devices

Topics: Buying medicine online, Diversion, and Fda

As part of the eighth annual International Internet Week of Action (IIWA), Food and Drug Administration (FDA), in collaboration with international regulatory and law enforcement agencies, took action against more than 1,050 websites that illegally sell potentially dangerous, unapproved prescription medicines and medical devices to consumers. 

Read More →

Drug Overdoses Doubled Over the Last 14 Years, Half Are Related to Prescription Drugs, Indicates New Report

Topics: Prescription drug abuse

Drug overdoses are now the leading cause of injury deaths in the United States, and half of those injuries, 22,000 per year, are related to prescription drugs, according to a new report from the Trust for America’s Health and the Robert Wood Johnson Foundation.

Read More →

Illinois Pilot Program Would Require Certain Hydrocodone Products to be Dispensed With Locking Mechanisms

Topics: Controlled substances

Illinois lawmakers have approved a pilot program that would add locking devices on some prescription painkiller prescriptions to ensure only the patient has access to the medication. 

Read More →

New Resource for Consumers to Identify Safe Online Pharmacies Promoted by NABP Executive Director

Topics: Counterfeit drugs and Buying medicine online

NABP Executive Director Carmen A. Catizone, MS, RPh, DPh, and Libby Baney, JD, executive director of the Alliance for Safe Online Pharmacies participated in a series of interviews to spread awareness about .pharmacy as a resource for consumers.

Read More →

NABP Continues to Fund PMP InterConnect Participation Supporting States’ Momentum in the Fight Against Prescription Drug Abuse

Topics: Prescription monitoring program

The National Association of Boards of Pharmacy® (NABP®), recognizing the importance of prescription monitoring programs (PMPs) and other state efforts to fight against prescription drug abuse and diversion, recently approved continued funding to support participation in NABP PMP InterConnect® at no cost to the state PMPs through June 2018.

Read More →

FDA Issues Draft Guidance on Compounding of Animal Drugs from Bulk Substances

Topics: Compounding and Fda

Food and Drug Administration (FDA) has released a draft guidance document related to the compounding of animal drugs from bulk substances.

Read More →